Sort   by:  
 Page size 
UnknownDefinitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
Not available
S-EPMC3757290 | biostudies-literature
UnknownMicrobial rhodopsins are major contributors to the solar energy captured in the sea.
Not available
S-EPMC6685716 | biostudies-literature
UnknownProspective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.
Not available
S-EPMC8462523 | biostudies-literature
UnknownStreamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial.
Not available
S-EPMC8332589 | biostudies-literature
UnknownIncidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
Not available
S-EPMC7726817 | biostudies-literature
UnknownAssociation of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant.
Not available
S-EPMC7273311 | biostudies-literature
UnknownBRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Not available
S-EPMC4907358 | biostudies-literature
UnknownOutcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant.
Not available
S-EPMC8283558 | biostudies-literature
UnknownReduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.
Not available
S-EPMC7362362 | biostudies-literature
UnknownA Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
Not available
S-EPMC9018520 | biostudies-literature
Sort   by:  
 Page size